home.aspx
 
EVENTS

Annual Pharma Pricing, Reimbursement & Market Access Conference
ANNUAL PHARMA PRICING, REIMBURSEMENT & MARKET ACCESS CONFERENCE
December 02-03, 2020
Annual Pharma Pricing, Reimbursement & Market Access will bring together top pharmaceutical, biotechnology and regulatory representatives under one roof that will address the key issues of the industry. It will focus on themes such as Preparing your best market access strategy, EU and US policy ...

Peptide Drug Design & Delivery Summit
PEPTIDE DRUG DESIGN & DELIVERY SUMMIT
December 01-03, 2020
The Peptide Drug Design & Delivery Summit will bring together key decision makers and innovators within this rapidly growing field. This intensive 3-Day program will examine various peptide discovery and synthesis techniques and synthesized and modified peptides. Hear from over 50 peptide drug c...

SHARESHARESHARE
Alma is pioneering a new practice model for therapists to elevate the therapy experience and simplify access to care. We build co-practicing communities powered by shared technology and services.
SHARESHARESHARE

RELATED NEWS


When Roche delayed its planned 4.8 billion dollars purchase of gene therapy developer Spark Therapeutics for the fifth time earlier this week, citing the Federal Trade Commissions FTCs review of the deal, one burning question emerged among pharma watchers- What the heck is the FTCs problem? Shortly thereafter, another troubling question bubbled up- If the FTC is going to be this nitpicky about one giant pharma company’s effort to buy a relatively small player, could that end up scuttling f...

READ MORE

А leading pharmaceutical firm Boehringer Ingelheim has teamed up with blockchain-based healthcare platform Solve.Care, according to a press release shared with Cointelegraph on June 6. Germany-based Boehringer, one of the world’s 20 largest pharma companies, and Solve.Care are planning to build a blockchain and digital asset-powered network for trusted sharing of data about patients with diabetes. Based on Solve.Care’s blockchain platform, the new healthcare system is known as the Di...

READ MORE

FORT LAUDERDALE, FL, UNITED STATES, April 8, 2019 /EINPresswire.com/ -- TRIFECTAPHARMACEUTICALS USA, a leading developer, manufacturer and distributor of specialty OTC topical ointments, creams and gels, today announces its inaugural distribution partnership with Walmart. Mayinglong hemorrhoid ointment, a known and trusted treatment for the pain and discomfort associated with hemorrhoids, will be available on Walmart’s shelves from April 2019. Mayinglong hemorrhoid ointment combines popula...

READ MORE

Recently, multinational retail corporation, Walmart and retail pharmacy, and health care firm CVS have disclosed that they have moved past their pricing disagreement of filling prescriptions. Earlier, the dispute was about the involvement of Walmart in CVS Caremark’s and Managed Medicaid pharmacy networks. The financial details of the multi-year agreement weren’t revealed. On January 14, 2019, CVS had revealed that Walmart was anticipated to leave the drugstore networks. This would h...

READ MORE

Litigation is growing over tainted blood pressure medications with a class-action lawsuit now filed in Florida against Walmart and three drug companies that span the supply chain. In addition to the retailer, the lawsuit names Indian drugmaker Aurobindo, U.S. drugmaker ScieGen Pharmaceuticals and distributor Westminster Pharmaceuticals. It was filed in federal court in Florida against the four over the sale of irbesartan because the drug contained the impurity, N nitrosodiethylamine (NDEA). The ...

READ MORE

Want to get serious about business development? Take a page from Pfizer’s playbook—and that’s exactly what Biogen is doing.On Thursday, the big biotech said it had brought on Pfizer veteran Dan Karp as its EVP of corporate development, ending his stint as the pharma giant’s VP of worldwide business development and head of R&D business development. For Biogen, Karp will lead a newly minted “corporate development function,” spanning business development and ...
FIERCEPHARMA
READ MORE

Biopharma in Charts aims to complement BioPharma Dive's daily news coverage with a data-driven look at a few of the top trends affecting the industry. This edition focuses on key takeaways from fourth quarter earnings, including strong returns from cancer drugs, growth drivers living up to the name, and the impact of a new U.S. tax code. Faster growth is forecast in 2018 for the biopharma industry, thanks to the recent overhaul to the U.S. tax code and attendant expectations of an uptick in ...
BIOPHARMADIVE
READ MORE

In big news for Northern Ireland-headquartered drug discovery group Almac, US regulators have awarded orphan drug status to the firm’s experimental therapy for ovarian cancer. ALM201 is a first-in-class therapeutic peptide developed to mimic some of the properties of the naturally occurring protein FKBPL, known to have an effect on a number of important tumour biology processes, including cancer stem cells and angiogenesis....

READ MORE

The 11th annual effort hosted by the Drug Enforcement Agency is set for 10 a.m. until 2 p.m., Saturday, April 29, at Walmart in Houston. All pharmaceuticals are accepted, including veterinary and over-the-counter drugs. No signatures are required and no questions are asked....

READ MORE

A new dual action drug developed as part of a collaboration between biopharmaceutical oncology firm Almac Discovery and The Royal College of Surgeons in Ireland (RCSI) could be used to treat cancer patients in whom all other treatment avenues have failed. In development for 10 years, ALM201 entered the clinical trial stage in 2015 and the research team at RCSI have now established the maximum tolerated dose, as lead researcher Proffesor Tracy Robson explained: “We started off with a low dose ...

READ MORE

EVENTS

Pharmacovigilance
PHARMACOVIGILANCE
December 01-03, 2020
Pharmacovigilance will bring together top pharmaceutical, biotechnology and regulatory representatives under one roof that will address the key issues of the industry. The entire program will cover the detection, analysis and prevention of adverse drug reactions. It will be studied with the help of ...

Controlled & Modified Drug Release Summit
CONTROLLED & MODIFIED DRUG RELEASE SUMMIT
December 01-03, 2020
By attending the unique Controlled & Modified Drug Release Summit, you will learn directly from 50+ of industry’s leading experts and hear multiple unique case study sessions and take-home examples to enhance your product pipeline. Gather insights into the latest technologies ...